Clinical Trials

87 enrolled 13 charts

Amyloidosis, Multiple Myeloma

NCT00224393 2023-05-30

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

60 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT02158052 2022-12-13

Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

2 enrolled 10 charts

Amyloidosis, Multiple Myeloma

NCT03678259 2022-03-25

124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis

57 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03923920 2021-12-22

ALF

200 enrolled

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Spinal Stenosis

NCT02716103 2021-09-10

MRD

45 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT02207556 2021-07-09

DUAL

32 enrolled 15 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00981708 2021-04-30

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

37 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Recurrence

NCT02545907 2021-04-15

CATALYST

10 enrolled 14 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

35 enrolled 9 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

NCT01383759 2020-04-07

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

20 enrolled 16 charts

Noninsulin-dependent diabetes mellitus with deafness, Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT03779815 2019-04-18

PET

14 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Amyloidosis, Multiple Myeloma

NCT00952237 2018-04-25

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Phase 1 Completed

13 enrolled

Amyloidosis, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT02791373 2018-04-03

ViGeM

136 enrolled

Amyloidosis, Multiple Myeloma

NCT02033928 2018-02-28

Comprehensive Frailty Assessment

Other hematologic neoplasmPlasma cell

111 enrolled

Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

25 enrolled 13 charts

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

NCT01194791 2017-04-25

LENDEXAL

30 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00890552 2017-03-22

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Other hematologic neoplasmPlasma cell

25 enrolled 12 charts

Amyloidosis, Leukemia

NCT01135849 2015-11-17

B-Receptor Signaling in Cardiomyopathy

BreastCNSClassical hematologyDermatologicEndocrineGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidNETOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

99 enrolled

Amyloidosis, Anemia, Anus Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Renal Cell, Colonic Neoplasms, Endocrine Gland Neoplasms, Esophageal Neoplasms, Eye Neoplasms, Gallbladder Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Leukemia, Lung Neoplasms, Lymphoma, Non-Hodgkin, Mesothelioma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neurologic Manifestations, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Phase 3 Completed

56 enrolled

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00621400 2011-05-10

Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

27 enrolled